Skip to main content
. 2018 Oct 12;13(10):e0204916. doi: 10.1371/journal.pone.0204916

Fig 2.

Fig 2

Viability of non-tumorigenic WB-F344 (a) and tumorigenic WB-ras cells (b) after treatment with PTM, μsPEFs or a combination of both, determined 3 h after treatment. The single treatments, i.e. with PTM or μsPEFs only, are compared to the combined treatments. Significant differences in cell viability are marked for the different treatment methods compared to control (*), for the combined treatments compared to the respective μsPEF-treatment alone (#) and between the two treatment orders (˄). Bars show mean values of three independent experiments performed in triplicates ± standard errors.